Symbol="APLS"
AssetType="Common Stock"
Name="Apellis Pharmaceuticals Inc"
Description="Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1492422"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4781300000"
EBITDA="-610880000"
PERatio="None"
PEGRatio="None"
BookValue="2.938"
DividendPerShare="0"
DividendYield="0"
EPS="-5.52"
RevenuePerShareTTM="1.63"
ProfitMargin="0"
OperatingMarginTTM="-3.319"
ReturnOnAssetsTTM="-0.399"
ReturnOnEquityTTM="-1.933"
RevenueTTM="184533000"
GrossProfitTTM="69786000"
DilutedEPSTTM="-5.52"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.818"
AnalystTargetPrice="65.29"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="51.26"
PriceToBookRatio="17.67"
EVToRevenue="42.79"
EVToEBITDA="-8.03"
Beta="1.17"
num_52WeekHigh="94.75"
num_52WeekLow="19.83"
num_50DayMovingAverage="51.25"
num_200DayMovingAverage="62.4"
SharesOutstanding="117737000"
DividendDate="None"
ExDividendDate="None"
symbol="APLS"
open="41.00"
high="43.12"
low="40.84"
price="42.21"
volume="1556378.00"
latest_trading_day="2023-08-31"
previous_close="40.61"
change="1.60"
change_percent="3.9399%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="34"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="3554785"
Change_recent_avg="-0.05"
Delta_recent_avg="3.22"
Variance_recent_avg="1.61"
Change_ratio_recent_avg="-0.34"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="1103"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_negative_thumbnail_id_2="139"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0037.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="608"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_positive_thumbnail_id_2="953"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1204"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
